Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Institute for Cancer and Blood Disorders
Wilmington, DE, USA
- Ownership
- Private
- Development stage
- Other
01
Overview
The Lisa Dean Moseley Foundation Institute for Cancer and Blood Disorders is a premier pediatric hematology and oncology research and clinical center located at Nemours Children's Hospital in Wilmington, Delaware. Established in 2023 through a transformative $78 million gift, the institute integrates advanced clinical care with groundbreaking research in areas such as sickle cell disease, leukemia, and solid tumors. It is a designated National Cancer Institute (NCI) Community Oncology Research Program (NCORP) and is recognized for its high enrollment in clinical trials. The institute's research pipeline includes innovative therapies like DLK1-targeted antibody-drug conjugates for myeloid leukemia. It provides comprehensive services including stem cell transplantation, cellular therapy, and specialized programs for rare blood disorders.
- Therapeutic areas
- OncologyHematology
- Modalities
- Antibody-drug conjugateCAR-T cell therapyStem cell transplantationImmunotherapySmall moleculeGene therapyBiologic
- Industry
- Academic Hospital/University/Research
02
Partnerships
ADC TherapeuticsChildren's Oncology GroupNational Cancer InstituteLeukemia & Lymphoma Society
Beyond the preview
Go deeper on Institute for Cancer and Blood Disorders.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Institute for Cancer and Blood Disorders.